BriaCell Therapeutics Corp. BCTX
Regular-session close
After hours · Nov 20, 5:59 PM ET
- YTD
- -56.96%
- 1 year
- -56.41%
BCTX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-28,778,372 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-07-31 | -28,778,372 | -607,852 | Not meaningful |
| FY 2025 | 2025-07-31 | -28,170,520 | -3,587,591 | Not meaningful |
| FY 2024 | 2024-07-31 | -24,582,929 | -838,069 | Not meaningful |
| FY 2023 | 2023-07-31 | -23,744,860 | -11,260,484 | Not meaningful |
| FY 2022 | 2022-07-31 | -12,484,376 | -4,734,188 | Not meaningful |
| FY 2021 | 2021-07-31 | -7,750,188 | -6,775,444 | Not meaningful |
| FY 2020 | 2020-07-31 | -974,744 | 2,218,634 | Not meaningful |
| FY 2019 | 2019-07-31 | -3,193,378 | 624,739 | Not meaningful |
| FY 2018 | 2018-07-31 | -3,818,117 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-30T05:30:02.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
